Long-Haul Covid-19

uMed Cohort

The Post-Acute Sequelae of SARS - CoV 2 Infection - Treatment Evaluation (PASC-TE) is the first real-world prospective cohort study to evaluate the impact of long-haul COVID based on therapeutic treatment.

PASC-TE Protocol Overview

Gain bespoke insights & outcomes. In one study.

  • Patient Journey Post-Covid
  • Disease Burden & Unmet Need of long-haul Covid
  • Long-term Treatment Effectiveness
  • Comparative Effectiveness
Book a demo Right Arrow

Clinical outcomes and PROs in the uMed PASC-TE Study

Among the data collected, key outcome measures to inform your research include:
  • Clinical Data (from patient’s EHR record)
    • Treatment History (inpatient / outpatient)
    • Hospitalisation for Covid-19 infection and treatment regimen
    • Comorbidities
    • Laboratory Data
  • Patient Reported Outcomes
    • Vaccination Status
    • Symptom Identification & Severity
    • Comorbidities (patient-reported)
    • HRQoL
    • Activities of Daily Living
    • Mental Health

Find out more

Book a complimentary demonstration

For a clear picture of how uMed could work for you, book a free session with our team.

    First name

    Last name

    Company or Institution


    Direct Line

    Set time

    Select a preferred time for us to call you


    Thanks Robert, we’ll call you on 07338 238329 on Tuesday 27th July
    between 8am and 11am